The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...

FDA approves the first subcutaneous version of nivolumab, making PD-1 inhibitors available to new groups of patients.

The FDA has approved Lilly's Zepbound, a glp-1 agonist, for the treatment of sleep apnea, which affects 25 million Americans ...

Tislelizumab-jsgr (Tevimbra) was approved in combination with chemotherapy for the treatment of unresectable or metastatic ...

Almost exactly 10 years after the FDA’s initial FDA approval for Bristol Myers Squibb’s Opdivo as the first PD-1 inhibitor in ...

A nationwide recall of enchiladas has been announced after the U.S. Food and Drug Administration (FDA) identified a potential ...

A discussion of the development of consumer protection law in the US through the enactment of key legislation and formation ...

The RELIEF ureteral stent, the brainchild of Dr. Lee Ponksy, chairman of UH’s Urology Institute, has been cleared by the U.S.

A Class I recall is used when "a violative product will cause serious adverse health consequences or death," according to the ...

“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...

The FDA and Alcon Laboratories recalled one lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count ...

The Food and Drug Administration (FDA) will begin collecting samples of raw cow’s milk cheese from across the U.S. to test ...